State v. Wakeen

57 N.W.2d 364, 263 Wis. 401, 1953 Wisc. LEXIS 422
CourtWisconsin Supreme Court
DecidedMarch 3, 1953
StatusPublished
Cited by29 cases

This text of 57 N.W.2d 364 (State v. Wakeen) is published on Counsel Stack Legal Research, covering Wisconsin Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
State v. Wakeen, 57 N.W.2d 364, 263 Wis. 401, 1953 Wisc. LEXIS 422 (Wis. 1953).

Opinion

Fairchild, J.

The pertinent sections of the statutes are as follows:

151.04 (2) “No person shall sell, give away, barter, compound, or dispense drugs, medicines, or poisons, nor permit it, in a town, village, or city with a population of 500 or more unless he be a registered pharmacist, nor institute nor conduct a place therefor without a registered pharmacist in charge, except that a registered assistant pharmacist may do so under the personal supervision of a registered pharmacist, and may have charge during the pharmacist’s necessary absence, not to exceed ten days. If the population is less than 500, only a registered assistant pharmacist is required.”
151.04 (3) “This shall not interfere with the dispensing of drugs, medicines, or other articles by physicians, nor with the sale of proprietary medicines in sealed packages, labeled to comply with the federal and state pure food and drug law, with directions for using, and the name and location of the manufacturer, nor with the sale of economic poisons for use in industrial arts, nor with the sale of economic poisons which comply with sections 94.67 to 94.71, nor with the sale of alum, ammonia, borax, bay rum, bicarbonate of soda, cream of tartar, concentrated lye, olive oil, sal ammoniac, sal soda, sulphur, copperas, epsom salts, glauber salts, castor oil, glyc-erine, senna leaves, indigo, blue vitriol, turpentine, wood alcohol, and denatured alcohol.”
*404 151.06 “The term ‘drug/ as used in thi's chapter, means: (1) Articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them, intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and
“(2) All other articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and
“(3) Articles (other than food) intended to affect the structure or any function of the body of man or other animals ; and
“(4) Articles intended for use as a component of any articles specified in subsections (1), (2), or (3); but does not include surgical, dental, or laboratory instruments, gases, oxygen therapy equipment, X-ray apparatus, or therapeutic lamps, their components, parts, or accessories; or equipment, instruments, apparatus, or contrivances used to render such articles effective in medical, surgical, or dental treatment; or . articles intended for use or consumption in or for mechanical, industrial, manufacturing, or scientific applications or purposes.”

The arguments advanced by the respondent upon this appeal were presented to the circuit court. As to the first issue, the trial court said:

“The first question then is whether the articles in question are proprietary medicines.
“Various definitions of the term ‘proprietary medicines’ have been presented to the court.
“Expert witnesses in testimony taken upon the hearing of the motions gave the following definitions:
“ ‘A proprietary medicine is one made according to the maker’s own formula, all or partly secret, named with the name of his own choice, put up in original packages bearing his name as well as the name of the medicine and directions for the use of the same.’ . . .
“Courts of other jurisdictions have given various definitions.
*405 “The Iowa court in State v. Jewett Market Co. (1929), 209 Iowa, 567, 228 N. W. 288, in considering whether aspirin was a proprietary medicine, stated as follows:
“ ‘In Ferguson v. Arthur, 117 U. S. 482, 6 Sup. Ct. 861, 863, 29 L. Ed. 979, the court said: “Proprietary” is defined thus in the Imperial Dictionary: “Belonging to ownership; as, proprietary rights.” In Webster: “Belonging or pertaining to a proprietor” — “proprietor” being defined, “One who has the legal right or exclusive title to anything, whether in possession or not; an owner.” In Worcester: “Relating to a certain owner or proprietor.” ’
'“ ‘In State v. Zotalis, 172 Minn. 132, 214 N. W. 766, the supreme court of Minnesota said “Aspirin is a coal-tar product commonly kept in drug stores and is used and sold for medicinal purposes. It is a drug or medicine within the statute. It is not a proprietary or patent medicine.” ’
“ ‘The record shows that aspirin was originally a proprietary medicine. It was discovered in Germany, its formula was secret, and the product was originally made only by the possessor of this secret formula. However, the formula has been discovered, and aspirin is now made by different pharmaceutical and chemical manufacturers, and it has entirely ceased to be a proprietary medicine. Therefore, it does not come within the exception noted in the statute referring to proprietary medicines.’
“The appellate court of Illinois has taken a different view in State v. Ridgeway Drug Co. 324 Ill. App. 585, 59 N. E. (2d) 351. The opinion of the court was not published, but the headnote provides:
“ ‘Proprietary medicines’ within the Pharmacy Act are those prepared, put up, and boxed and ready for use by the public as soon as they leave the manufacturer’s hands. Smith-Hurd Stats, ch. 91, sec. 36.
“All three of the articles in question have been held to be drugs and not proprietary medicines:
“Milk of Magnesia — State of Minnesota v. F. W. Woolworth (1931), 184 Minn. 51, 237 N. W. 817, 76 A. L. R. 1202.
“Aspirin — State v. Jewett Market (1929), 209 Iowa, 567, 228 N. W. 288; State v. Zotalis (1927), 172 Minn. 132, 214 N. W. 766.
*406 “Camphorated Oil —Board of Pharmacy v. Abramoff (1928), 141 Atl. 587, 6 N. J. Mise. 437; Kratky v. Board of Pharmacy (1929), 7 N. J. Misc. 970, 147 Atl. 726.
“The defendant contends that all three articles are common, harmless, useful household articles sold in their original containers, and that the pharmacist performs no function other than selling, and that the articles are, therefore, for no real or practical purpose different than recognized patent or proprietary medicines as far as the public is concerned and should be classified as proprietary medicines within the meaning of the statute.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Monsanto Co. v. Office of Envtl. Health Hazard Assessment
231 Cal. Rptr. 3d 537 (California Court of Appeals, 5th District, 2018)
Gutierrez v. Industrial Commission
243 P.3d 604 (Court of Appeals of Arizona, 2010)
State v. Rhine
297 S.W.3d 301 (Court of Criminal Appeals of Texas, 2009)
State of Texas v. Rhine, Michael Joseph
Court of Criminal Appeals of Texas, 2009
Madrid v. St. Joseph Hospital
928 P.2d 250 (New Mexico Supreme Court, 1996)
Dane County Hospital & Home v. Commission
371 N.W.2d 815 (Court of Appeals of Wisconsin, 1985)
Lucas v. Maine Commission of Pharmacy
472 A.2d 904 (Supreme Judicial Court of Maine, 1984)
State Ex Rel. La Follette v. Stitt
338 N.W.2d 684 (Wisconsin Supreme Court, 1983)
Opinion No. Oag 33-83, (1983)
72 Op. Att'y Gen. 121 (Wisconsin Attorney General Reports, 1983)
Niagara of Wisconsin Paper Corp. v. Department of Natural Resources
268 N.W.2d 153 (Wisconsin Supreme Court, 1978)
Opinion No. Oag 104-77, (1977)
66 Op. Att'y Gen. 331 (Wisconsin Attorney General Reports, 1977)
Opinion No. Oag 36-77, (1977)
66 Op. Att'y Gen. 137 (Wisconsin Attorney General Reports, 1977)
Jennings v. Exeter-West Greenwich Regional School District Committee
352 A.2d 634 (Supreme Court of Rhode Island, 1976)
Osco Drug, Inc. v. Pharmacy Examining Board
214 N.W.2d 47 (Wisconsin Supreme Court, 1974)
Kugler v. Yocum
445 P.2d 303 (California Supreme Court, 1968)
Loblaw, Inc. v. New York State Board of Pharmacy
181 N.E.2d 621 (New York Court of Appeals, 1962)
Loblaw, Inc. v. New York State Board of Pharmacy
12 A.D.2d 180 (Appellate Division of the Supreme Court of New York, 1961)

Cite This Page — Counsel Stack

Bluebook (online)
57 N.W.2d 364, 263 Wis. 401, 1953 Wisc. LEXIS 422, Counsel Stack Legal Research, https://law.counselstack.com/opinion/state-v-wakeen-wis-1953.